Macrolide analog F806 suppresses esophageal squamous cell carcinoma (ESCC) by blocking β1 integrin activation

The paucity of new drugs for the treatment of esophageal squamous cell carcinoma (ESCC) limits the treatment options. This study characterized the therapeutic efficacy and action mechanism of a novel natural macrolide compound F806 in human ESCC xenograft models and cell lines. F806 inhibited growth...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Oncotarget
Main Authors: Li, Li-Yan, Jiang, Hong, Xie, Yang-Min, Liao, Lian-Di, Cao, Hui-Hui, Xu, Xiu-E, Chen, Bo, Zeng, Fa-Min, Zhang, Ying-Li, Du, Ze-Peng, Chen, Hong, Huang, Wei, Jia, Wei, Zheng, Wei, Xie, Jian-Jun, Li, En-Min, Xu, Li-Yan
Formato: Artigo
Idioma:Inglês
Publicado em: Impact Journals LLC 2015
Assuntos:
Research Paper
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC4599248/
https://ncbi.nlm.nih.gov/pubmed/25909284
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados